As of 2024-12-14, the Fair Value of BiVictriX Therapeutics PLC (BVX.L) is -16.18 GBP. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 10.00 GBP, the upside of BiVictriX Therapeutics PLC is -261.83%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | - | 5Y Avg | |
| Net income | -2.34 | -2.50 | -2.54 | - | -2.46 | |
| YoY growth | -444.19% | -6.71% | -1.92% | - | -150.94% | |
| Market Cap (mil) | 8.25 |
| P/E | |
| Forward P/E |
| EPS | -3.24 |
| Avg earnings growth rate | -150.94% |
| TTM earnings | -2.67 |